Drug recall · April 3, 2013
TORISEL Kit recall
Why: Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
TORISEL Kit (temsirolimus) injection, 25 mg/mL, CONCENTRATED, Rx Only, Packaged in a carton containing 1 vial TORISEL injection and 1 vial DILUENT for TORISEL, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA --- NDC 0008-1179-01
- Lots / codes
Lots P00025A; P00027B
- Quantity
- 10920 kits
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide
- Initiated
- November 26, 2012 · Voluntary: Firm initiated
- Classified
- March 26, 2013
- Reported
- April 3, 2013
- Ended
- March 31, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Temsirolimus
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.